{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:55:28Z","timestamp":1764402928132,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007915","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["HHSN272200800002C","HHSN272201300015I"],"award-info":[{"award-number":["HHSN272200800002C","HHSN272201300015I"]}],"id":[{"id":"10.13039\/100007915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","award":["HHSN272200800005C","HHSN272201300018I"],"award-info":[{"award-number":["HHSN272200800005C","HHSN272201300018I"]}],"id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","award":["HHSN272200800006C"],"award-info":[{"award-number":["HHSN272200800006C"]}],"id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children\u2019s Mercy Hospital Kansas City","award":["HHSN272200800008C"],"award-info":[{"award-number":["HHSN272200800008C"]}]},{"name":"St. Louis University","award":["HSN272200800003C"],"award-info":[{"award-number":["HSN272200800003C"]}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["HHSN272200800007C","HHSN272201300023I"],"award-info":[{"award-number":["HHSN272200800007C","HHSN272201300023I"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Maryland School of Medicine","award":["HHSN 272201300022I"],"award-info":[{"award-number":["HHSN 272201300022I"]}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","award":["HHSN272201300017I"],"award-info":[{"award-number":["HHSN272201300017I"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Emmes Corporation","award":["HHSN272201500002C"],"award-info":[{"award-number":["HHSN272201500002C"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.085","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T18:17:08Z","timestamp":1564510628000},"page":"5161-5170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-7689","authenticated-orcid":false,"given":"Flor M.","family":"Munoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Pahud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Buddy","family":"Creech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Kotloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6772","authenticated-orcid":false,"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbie R.","family":"Bellamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soju","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.085_b0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.07.085_b0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(99)03311-5","article-title":"Human infection with influenza H9N2","volume":"354","author":"Peiris","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.085_b0015","unstructured":"CDC. Emergence of Avian influenza A(H7N9) Virus Causing Severe Human Illness \u2013 China, February-April 201MMWR 2013 May 10; 62(18): 366\u201371."},{"key":"10.1016\/j.vaccine.2019.07.085_b0020","unstructured":"CDC. Update: Influenza A (H3N2)v Transmission and Guidelines \u2013 Five States, 2011. MMWR 2012; 60: 1741\u20134."},{"key":"10.1016\/j.vaccine.2019.07.085_b0025","unstructured":"CDC. Swine-origin influenza A (H3N2) virus infection in two children \u2013 Indiana and Pennsylvania, July-August 2011. MMWR 2011; 60: 1213\u20135."},{"key":"10.1016\/j.vaccine.2019.07.085_b0030","unstructured":"CDC. Limited human-to-human transmission of novel influenza A (H3N2) virus \u2013 Iowa, November 2011. MMWR 2011; 60: 1615\u20137."},{"key":"10.1016\/j.vaccine.2019.07.085_b0035","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/512813","article-title":"Cases of swine influenza in humans: a review of the literature","volume":"44","author":"Myers","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.085_b0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3201\/eid1805.111922","article-title":"Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011","volume":"18","author":"Lindstrom","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.085_b0045","unstructured":"CDC. Outbreak of influenza A (H3N2) virus among persons and swine at a county fair-Indiana, July 2012. MMWR 2012; 61: 561."},{"key":"10.1016\/j.vaccine.2019.07.085_b0050","unstructured":"CDC. CDC reports cases 18-29 of H3N2v virus infection; continues to recommend interim precautions when interacting with pigs. http:\/\/www.cdc.gov\/flu\/spotlights\/h3n2v_us_cases.htm."},{"key":"10.1016\/j.vaccine.2019.07.085_b0055","unstructured":"Centers for Disease Control and Prevention. Influenza A (H3N2) Variant Viruses; https:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-cases.htm [June 2018]."},{"issue":"39","key":"10.1016\/j.vaccine.2019.07.085_b0060","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.15585\/mmwr.mm6639a3","article-title":"Update: Influenza activity \u2013 United States and worldwide, May 21-September 23, 2017","volume":"66","author":"Blanton","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"10.1016\/j.vaccine.2019.07.085_b0065","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.19.20170-en","article-title":"Age-dependent prevalence of antibodies cross reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011","volume":"17","author":"Waalen","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.07.085_b0070","first-page":"237","article-title":"Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010\u20132011 seasonal influenza vaccine on cross-reactive antibodies \u2013 United States","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.07.085_b0075","doi-asserted-by":"crossref","first-page":"20066","DOI":"10.2807\/ese.17.04.20066-en","article-title":"Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010\/11 trivalent inactivated influenza vaccine in Canada, August to November 2010","volume":"17","author":"Skowronski","year":"2012","journal-title":"Euro Surveill"},{"issue":"12","key":"10.1016\/j.vaccine.2019.07.085_b0080","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/infdis\/jis500","article-title":"Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza a virus subtype H3N2 (H3N2v)","volume":"206","author":"Skowronski","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.085_b0085","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/jiv056","article-title":"Safety and Immunogenicity of a subvirion monovalent unadjuvanted inactivated influenza A(H3N2) variant vaccine in healthy persons > 18 years old","volume":"212","author":"Keitel","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.085_b0090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.07.085_b0095","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A(H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.085_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054015","article-title":"H3N2v and other influenza epidemic risk based on age specific estimates of sero-protection and contact network interactions","volume":"8","author":"Skowronski","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:55Z","timestamp":1759401475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":20,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19310060"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}